Evidence map›Paper›PMID 42755479›Full record

ArticleBioinformatics advances2026

pLM-SAV: a Δ-embedding approach for predicting pathogenic single amino acid variants.

Orsolya Gereben, Hedvig Tordai, Lana Khamisi, Erda Qorri, Tamás Hegedűs

Abstract read
In one paragraph

Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Orsolya GerebenDepartment of Biophysics and Radiation Biology, Semmelweis University, Budapest 1094, Hungary.ORCID https://orcid.org/0000-0001-5038-9809
Hedvig TordaiDepartment of Biophysics and Radiation Biology, Semmelweis University, Budapest 1094, Hungary.
Lana KhamisiDepartment of Biophysics and Radiation Biology, Semmelweis University, Budapest 1094, Hungary.
Erda QorriMutagenesis and Carcinogenesis Research Group, HCEMM-HUN-REN BRC, Szeged 6728, Hungary.
Tamás HegedűsDepartment of Biophysics and Radiation Biology, Semmelweis University, Budapest 1094, Hungary.ORCID https://orcid.org/0000-0002-5195-749X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: Predicting whether single amino acid variants (SAVs) in proteins lead to pathogenic outcomes is a critical challenge in molecular biology and precision medicine. Experimental determination of all possible mutation effects is infeasible, and while state-of-the-art tools such as AlphaMissense show promise, their diagnostic performance is insufficient and they are often difficult to run locally. Results: We developed pLM-SAV, a simple yet effective predictor that leverages protein language models (pLMs). Δ-embeddings, computed as the difference between wild-type and mutant sequence embeddings, are used as input for a convolutional neural network. We trained our model on a well-characterized, labelled set of Eff10k and evaluated it on a non-homologous subset of ClinVar data. This approach performs exceptionally well on the Eff10k test folds and reasonably on ClinVar test sets. On ambiguity-defined subsets, pLM-SAV provides complementary predictions to AlphaMissense and REVEL, although these methods retain higher overall performance on broad ClinVar benchmarks. Our results show that a compact predictor trained on labelled variant-effect data can provide useful predictive performance across multiple benchmarks. Unlike previous methods such as VESPA, pLM-SAV uses no handcrafted features or substitution matrices, relying solely on pLM-derived representations. Δ-embedding-based features may provide useful additional signals for future mutation-effect predictors or integrative models. Availability and implementation: The code is available at https://doi.org/10.5281/zenodo.15502498.

Identifiers

PMID42755479
PMCPMC13581460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.